Randomized phase II trial of Gemcitabine and Paclitaxel with or without maintenance treatment in patients with cisplatin refractory transitional cell carcinoma

被引：0
|
作者：
Fechner, GH
Siener, R
Reimann, M
Strunk, R
Golinski, C
Heimbach, D
Wiebusch, H
Langbein, S
Ehlert, C
Bannowsky, A
Heidenreich, A
Kühn, M
Albers, P
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 409S - 409S
  • [2] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [3] Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial
    Bajorin, DF
    McCaffrey, JA
    Hilton, S
    Mazumdar, M
    Kelly, WK
    Scher, HI
    Spicer, J
    Herr, H
    Higgins, G
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2722 - 2727
  • [4] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with infiltrative transitional cell carcinoma of the urothelium
    Ecke, T. K.
    Bartel, P.
    Theissig, F.
    Koch, S.
    Ruttloff, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 220 - 220
  • [5] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Ecke, Thorsten H.
    Bartel, Peter
    Koch, Stefan
    Ruttloff, Juergen
    Theissig, Franz
    ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
  • [6] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [7] Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Mazumdar, M
    Russo, P
    Sheinfeld, J
    Donat, SM
    Bochner, BH
    Herr, HW
    Sogani, P
    Ginty, J
    Bajorin, DF
    JOURNAL OF UROLOGY, 2004, 171 (04): : 72 - 72
  • [8] Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium:: A phase II clinical trial
    von der Maase, H
    Andersen, L
    Crinò, L
    Weinknecht, S
    Dogliotti, L
    ANNALS OF ONCOLOGY, 1999, 10 (12) : 1461 - 1465
  • [9] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Ben-Porat, L
    Donat, SM
    Herr, HW
    Bochner, BH
    Bajorin, DF
    JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
  • [10] Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
    Lu, Zhihao
    Zhang, Yanqiao
    Fan, Qingxia
    Pan, Yueyin
    Jiang, Da
    Lu, Ping
    Zhang, Jingdong
    Yuan, Xianglin
    Feng, Jifeng
    Yang, Shujun
    Yue, Wenbin
    Zhao, Lin
    Xu, Yunhua
    Luo, Jinhua
    Shen, Lin
    INNOVATION, 2022, 3 (03):
12345